Radiation Oncology/Therapy

ASTRO: Radiotherapy offers opportunities beyond cancer treatment
By Kate Madden Yee
September 28, 2025
Am 2018 10 21 20 23 4419 Astro 20181022040021
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
September 26, 2025
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
Accuray introduces Stellar adaptive radiotherapy system
By AuntMinnie.com staff writers
Stellar expands the range of available radiation delivery options offered by Accuray.
September 26, 2025
Accuray Astro 2019 Social
Philips launches new radiation oncology offerings
By AuntMinnie.com staff writers
The company is debuting Rembra RT and Areta RT CT platforms and helium free BlueSeal RT 1.5T 70cm MR system.
September 26, 2025
Philips' Rembra RT CT platform
GE HealthCare to debut updates to iRT at ASTRO 2025
By AuntMinnie.com staff writers
GE HealthCare plans to debut updates to Intelligent Radiation Therapy (iRT) for radiation oncology workflows.
September 25, 2025
Ge Health Care Logo
ITM and TerThera ink supply deal for Tb-161
By AuntMinnie.com staff writers
Like Lutetium-177, Tb-161 emits medium-range beta particles and has a similar half-life.
September 24, 2025
Isotopes1
Radiation oncologists put RefleXion’s X1 system to the test
By Will Morton
A pilot study demonstrates the potential feasibility of using RefleXion's X1 unit in patients with prostate cancer.
September 19, 2025
An example of a typical BgRT plan: A) PET scan on diagnostic PET/CT and B) X1 PET-Linac for patient #15 with a PET avid rib metastasis with GTV size= 3.1 cc, PTV = GTV + 5mm, BTZ (biological tracking zone) = PTV + 5 mm, AC = 14.33 kBq/mL and NTS = 21.04. Red, magenta, and green contours represent GTV, PTV, and BTZ. C) Dose distribution and D) bounded-DVH of a BgRT plan are displayed for the same patient. The bounded Dose-Volume Histogram (DVH) models variations in BgRT delivery, encompassing fluctuation in target background signal variation, target localization and dose delivery uncertainties.
Radiation organizations issue guidance on postmastectomy radiation therapy
By Maryam Payne
ASTRO, ASCO, and SSO have jointly issued updated guidelines on postmastectomy radiation therapy.
September 16, 2025
Radiation Therapy Suite
FDA clears Mevion's S250-FIT proton therapy system
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared Mevion Medical Systems' S250-FIT proton therapy system.
September 15, 2025
Am 2019 09 17 16 16 6880 Mevion Astro 2019
ASTRO takes aim at proposed 2026 MPFS provisions
By AuntMinnie.com staff writers
Society says more work is needed on comprehensive payment reform for radiation oncology.
September 12, 2025
Astro 2019 Social (1)
The rise of theranostics: Part 6 -- Private practices pivot to clinical trials
By Liz Carey
Regional capacity slowly builds for burgeoning demand, but data is lacking on nuclear medicine and theranostics needs across the U.S.
September 12, 2025
Rise Of Thernostics Part 6 Thumbnail
RaySearch releases oncology analytics platform update
By AuntMinnie.com staff writers
Software provider RaySearch Laboratories has released RayIntelligence v2025, an update of its oncology analytics platform.
September 2, 2025
Raysearch Astro 2019
Page 1 of 465
Next Page